Here, the demonstration of a critical axis of EZH2-HNF1B/RBBP7-SLUG in prostate cancer development, provides mechanistic insights of EZH2-mediated prostate tumorigenesis and molecular basis for the application of EZH2 inhibitors. This evidence concerns the gene HNF1B and prostate cancer.